Published in
BMJ Publishing Group, Annals of the Rheumatic Diseases, p. annrheumdis-2021-221816, 2021
DOI: 10.1136/annrheumdis-2021-221816
Links
Tools
Response to: Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physicianreported spondylitis’?’ by Braun and Landewe
Journal article published in 2021 by
Juergen Braun 
,
Robert Bm Landewé
,
Robert Bm Landewé
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 